Physician profile
Timothy C Ball
NPI 1073622031
$5,667.76
in general payments reported to CMS, 2019-2025
11 companies · $385 in 2025
The $385 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,938 · 2020: $82.92 · 2023: $168 · 2024: $94.44 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $647.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tryton Medical, INC. | $4,600.00 | 2019 | |
| Biosense Webster, INC. | $445.67 | 2024-2025 | Carto 3 |
| Boston Scientific Corporation | $232.36 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $131.22 | 2019 | |
| Janssen Pharmaceuticals, INC | $73.53 | 2019-2020 | |
| Pfizer INC. | $49.89 | 2019-2020 | |
| Amgen INC. | $49.81 | 2019-2020 | |
| Becton, Dickinson and Company | $33.36 | 2025 | True Flow |
| Astrazeneca Pharmaceuticals LP | $20.48 | 2020 | |
| Novartis Pharmaceuticals Corporation | $18.99 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.